Aura Biosciences, Inc.
AURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $408 | $351 | $314 | $496 |
| - Cash | $32 | $41 | $122 | $149 |
| + Debt | $19 | $20 | $21 | $1 |
| Enterprise Value | $395 | $330 | $214 | $348 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$95 | -$84 | -$59 | -$34 |
| % Margin | – | – | – | – |
| Net Income | -$87 | -$76 | -$59 | -$35 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.75 | -1.93 | -1.96 | -1.58 |
| % Growth | 9.3% | 1.5% | -24.1% | – |
| Operating Cash Flow | -$80 | -$64 | -$55 | -$32 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$2 |
| Free Cash Flow | -$81 | -$65 | -$56 | -$35 |